drugset / Trial / NCT03323671

Preemptive Analgesia for Primary Dysmenorrhoea

NCT03323671

Phase 2/3 Completed 84 enrolled Hanan Nabil
RandomizedParallel-groupOpen-labelSupportive care

Summary

Preemptive analgesia before the release of pain mediators

Timeline

Start
2017-08-01
Primary completion
2017-12-01
Completion
2017-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mefenamic acid Small molecule 500 mg

Indications